Fortress Biotech (FRA:CNB0.PFD) Change In Receivables : €-8.21 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Fortress Biotech Change In Receivables?

Fortress Biotech's change in receivables for the quarter that ended in Mar. 2025 was €-7.52 Mil. It means Fortress Biotech's Accounts Receivable increased by €7.52 Mil from Dec. 2024 to Mar. 2025 .

Fortress Biotech's change in receivables for the fiscal year that ended in Dec. 2024 was €4.27 Mil. It means Fortress Biotech's Accounts Receivable declined by €4.27 Mil from Dec. 2023 to Dec. 2024 .

Fortress Biotech's Accounts Receivable for the quarter that ended in Mar. 2025 was €16.67 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Fortress Biotech's Days Sales Outstanding for the three months ended in Mar. 2025 was 125.18.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Fortress Biotech's liquidation value for the three months ended in Mar. 2025 was €-31.89 Mil.

Fortress Biotech Change In Receivables Historical Data

The historical data trend for Fortress Biotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Change In Receivables Chart

Fortress Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-8.48

0.74

-4.57

11.48

4.27

Fortress Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															4.84	-0.66	-0.75	0.72	-7.52

Fortress Biotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.21 Mil.

Fortress Biotech (FRA:CNB0.PFD) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Fortress Biotech's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	16.673	/	12.154	*	91
=	125.18

2. In Ben Graham's calculation of liquidation value, Fortress Biotech's accounts receivable are only considered to be worth 75% of book value:

Fortress Biotech's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	84.489	-	134.666	+	0.75 * 16.673	+	0.5 * 11.559
=	-31.89

Fortress Biotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortress Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (FRA:CNB0.PFD) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

FBIOP.PFD:USA FBIO:USA

Address

1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website

https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Fortress Biotech Headlines

No Headlines